APOGEE THERAPEUTICS, INC.
Ownership & governance
Executives 5Directors 7Avg age 48Avg tenure 3.2y
MH
Michael Henderson
Chief Executive Officer
Age 36Since 2022-08-31Profile →
+11
Executives5
MH
Michael Henderson→
Chief Executive Officer
Age 36Since 2022-08-31
JH
Jane Henderson→
Director of Finance/CFO
Age 60Since 2022-12-31
TP
Tim Piringer→
Chief Tech/Sci/R&D Officer
—Since 2023-04-30
CD
Carl Dambkowski→
Chief Tech/Sci/R&D Officer
Age 41Since 2022-08-31
NK
Noël Kurdi→
Investor Relations Contact
—Since 2023-06-30
Board of directors7
JF
Jennifer Fox→
Director/Board Member
Age 54Since 2023-06-21
WJ
William Jones→
Director/Board Member
Age 62Since 2023-05-31
MH
Michael Henderson→
Director/Board Member
Age 36Since 2023-05-31
TK
Tomas Kiselak→
Director/Board Member
Age 39Since 2023-05-31
NS
Nimish Shah→
Director/Board Member
Age 48Since 2023-05-31
MM
Mark McKenna→
Chairman
Age 46Since 2023-08-16
LB
Lisa Bollinger→
Director/Board Member
Age 61Since 2024-05-27
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 18.4 % | 10,300,984 |
| T. Rowe Price Investment Management, Inc. | 18.38 % | 10,291,220 |
| Fidelity Management & Research Co. LLC | 16.54 % | 9,262,291 |
| Wellington Trust Co., NA | 7.814 % | 4,375,703 |
| BlackRock Advisors LLC | 6.654 % | 3,725,885 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Carl Dambkowski | Chief Tech/Sci/R&D Officer | 2022-08-31 | - |
| Jane Henderson | Director of Finance/CFO | 2022-12-31 | - |
| Mark McKenna | Chairman | 2023-08-16 | - |
| Michael Henderson | Chief Executive Officer | 2022-08-31 | - |
| Tim Piringer | Chief Tech/Sci/R&D Officer | 2023-04-30 | - |
| Jennifer Fox | Director/Board Member | 2023-06-21 | - |
| Lisa Bollinger | Director/Board Member | 2024-05-27 | - |
| Michael Henderson | Director/Board Member | 2023-05-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus holdMean target 134.62Range 133–135.11Analysts 5
133Mean 134.62135.11
- Buy 1
- Hold 6
Broker actions40 of 58
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Hold | 135 | 2026-08-13 |
| BTIG | Downgrade | Neutral | — | 2026-08-12 |
| Stifel | Downgrade | Hold | 135 | 2026-06-24 |
| TD Cowen | Downgrade | Hold | — | 2026-06-24 |
| Guggenheim | Downgrade | Neutral | — | 2026-06-24 |
| Mizuho | Downgrade | Neutral | 135 | 2026-06-24 |
| Deutsche Bank | Downgrade | Hold | 135 | 2026-06-23 |
| Citigroup | Downgrade | Neutral | 135 | 2026-06-23 |
| RBC Capital | Maintained | Sector Perform | 135 | 2026-06-23 |
| UBS | Downgrade | Neutral | 135.11 | 2026-06-23 |
| Wedbush | Downgrade | Neutral | 135 | 2026-06-23 |
| Canaccord Genuity | Downgrade | Hold | 135.11 | 2026-06-22 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.